Estimating the relapse stage in chronic myeloid leukaemia patients after allogeneic stem cell transplantation by the amount of BCR-ABL fusion transcripts detected using a new real-time polymerase chain reaction method

TitleEstimating the relapse stage in chronic myeloid leukaemia patients after allogeneic stem cell transplantation by the amount of BCR-ABL fusion transcripts detected using a new real-time polymerase chain reaction method
Publication TypeJournal Article
Year of Publication2001
AuthorsElmaagacli AH, Freist A, Hahn M, Opalka B, Seeber S, Schaefer UW, Beelen DW
JournalBr J Haematol
Volume113
Issue4
Pagination1072 - 5
Date PublishedJun
Accession Number11442504
Keywords*Hematopoietic Stem Cell Transplantation, Adolescent, Adult, Comparative Study, Cytogenetic Analysis, Female, Fusion Proteins, bcr-abl / *genetics, Humans, In Situ Hybridization, Fluorescence, Leukemia, Myeloid, Chronic / *diagnosis / *surgery, Male, Middle Aged, Polymerase Chain Reaction / methods, Recurrence, Research Support, Non-U.S. Gov't, Transplantation, Homologous
Abstract

We have used a new single-step real-time reverse transcription polymerase chain reaction (RT-PCR) method to quantify BCR-ABL transcripts, thereby estimating the relapse stage in chronic myeloid leukaemia patients after allogeneic transplants. In 402 samples from 172 patients, BCR-ABL expression was determined and normalized, using the GAPDH housekeeping gene product as an endogenous reference. In our real-time RT-PCR assay, serial dilutions of RNA of the K562 cell line remained positive down to 7.5 pg. The median normalized BCR-ABL amount differed significantly (P

Notify Library Reference ID482

Related Incidents